Oxymetazoline in the treatment of posterior epistaxis.

Simple item page
dc.contributor.authorDoo, G
dc.contributor.authorJohnson, D S
dc.date.accessioned2016-10-25T23:19:39Z
dc.date.available2016-10-25T23:19:39Z
dc.date.issued1999-08
dc.description.abstractIn this retrospective study, 36 patients were given oxymetazoline as a first step in treatment for posterior epistaxis. In 75% of the cases, epistaxis was effectively treated with oxymetazoline with no recurrent bleeding. All cases with recurrence resolved with continued administration of oxymetazoline. The results of this study propose a pharmacologic intervention for the treatment of posterior epistaxis.
dc.identifier.issn0017-8594
dc.identifier.pubmed10487000
dc.identifier.urihttp://hdl.handle.net/10524/53890
dc.language.isoeng
dc.subject.meshAdult
dc.subject.meshAged
dc.subject.meshEpistaxis/drug therapy/etiology
dc.subject.meshFemale
dc.subject.meshHumans
dc.subject.meshMale
dc.subject.meshMiddle Aged
dc.subject.meshNasal Decongestants/therapeutic use
dc.subject.meshOxymetazoline/therapeutic use
dc.subject.meshRecurrence
dc.subject.meshRetrospective Studies
dc.subject.meshTreatment Outcome
dc.titleOxymetazoline in the treatment of posterior epistaxis.
dc.typeArticle
dc.type.dcmiText
prism.number8
prism.pagerange210-2
prism.publicationnameHawaii Medical Journal
prism.volume58

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
1999-08p210-212.pdf
Size:
262.92 KB
Format:
Adobe Portable Document Format
Download

Collections

Hawaii Medical Journal Articles For 1999